Development of an Immune-Related Risk Signature in Patients with Bladder Urothelial Carcinoma

Figure 4

Heatmap of the signature consisting of 10 immune-related genes used to construct the immune-related risk signature for BLCA (a–c). The Kaplan–Meier survival analysis of the signature (d). ROC curve analysis of the signature (e). The Cox analysis of the signature and clinicopathological factors: the univariate Cox analysis (f); the multivariate Cox analysis (g).

(a)

(b)

(c)

(d)

(e)

(f)

(g)